http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003082670-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-49 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-49 |
filingDate | 2002-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73155abe749ea1456612db9c6ee49a1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efa10583c7ded95690c3ae3a01cd4ef3 |
publicationDate | 2003-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2003082670-A1 |
titleOfInvention | Platelet-derived growth factor C, DNA coding therefor, and uses thereof |
abstract | PDGF-C, a new member of the PDGF/VEGF family of growth factors, is described, as well as nucleotide sequences, its method of production, antibodies and antagonists. Also disclosed are transfected and transformed host cells expressing same and pharmaceutical compositions, and uses thereof in medical and diagnostic applications. Proteolytic processing of PDGF-C is accomplished by a serine protease. Methods for inhibiting PDGF-C activities and for treating disease caused by PDGF-C over-activity of over-expression are also disclosed. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009118699-A1 |
priorityDate | 1998-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 470.